Page last updated: 2024-09-03

gefitinib and 6-aminonicotinamide

gefitinib has been researched along with 6-aminonicotinamide in 1 studies

Compound Research Comparison

Studies
(gefitinib)
Trials
(gefitinib)
Recent Studies (post-2010)
(gefitinib)
Studies
(6-aminonicotinamide)
Trials
(6-aminonicotinamide)
Recent Studies (post-2010) (6-aminonicotinamide)
5,2315662,919342135

Protein Interaction Comparison

ProteinTaxonomygefitinib (IC50)6-aminonicotinamide (IC50)
Nicotinamide N-methyltransferaseHomo sapiens (human)3.62

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Chang, H; Chen, G; Chen, Y; Ding, J; Huang, R; Ji, D; Song, B; Yuan, L1

Other Studies

1 other study(ies) available for gefitinib and 6-aminonicotinamide

ArticleYear
Multiple myeloma acquires resistance to EGFR inhibitor via induction of pentose phosphate pathway.
    Scientific reports, 2015, Apr-20, Volume: 5

    Topics: 6-Aminonicotinamide; Afatinib; Cell Line, Tumor; Cell Proliferation; Drug Resistance, Neoplasm; Drug Synergism; ErbB Receptors; Gefitinib; Glucose; Humans; Metabolome; Multiple Myeloma; Oxygen; Pentose Phosphate Pathway; Protein Kinase Inhibitors; Proto-Oncogene Proteins B-raf; Quinazolines; ras Proteins; Receptor, ErbB-2; RNA, Small Interfering; TOR Serine-Threonine Kinases

2015